Vito J. Palombella

2021 - Surface Oncology

In 2021, Vito J. Palombella earned a total compensation of $1.2M as Chief Scientific Officer at Surface Oncology, a 7% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$192,000
Option Awards$527,768
Salary$428,490
Other$12,756
Total$1,161,014

Palombella received $527.8K in option awards, accounting for 45% of the total pay in 2021.

Palombella also received $192K in non-equity incentive plan, $428.5K in salary and $12.8K in other compensation.

Rankings

In 2021, Vito J. Palombella's compensation ranked 8,246th out of 12,415 executives tracked by ExecPay. In other words, Palombella earned more than 33.6% of executives.

ClassificationRankingPercentile
All
8,246
out of 12,415
34th
Division
Manufacturing
3,652
out of 5,505
34th
Major group
Chemicals And Allied Products
1,624
out of 2,375
32nd
Industry group
Drugs
1,444
out of 2,096
31st
Industry
Biological Products, Except Diagnostic Substances
320
out of 449
29th
Source: SEC filing on April 26, 2022.

Palombella's colleagues

We found three more compensation records of executives who worked with Vito J. Palombella at Surface Oncology in 2021.

2021

Robert Ross

Surface Oncology

Chief Executive Officer

2021

Alison O'Neill

Surface Oncology

Chief Medical Officer

2021

J Goater

Surface Oncology

Chief Executive Officer

News

You may also like